Neurotrophic keratitis

被引:291
作者
Bonini, S
Rama, P
Olzi, D
Lambiase, A
机构
[1] Interdisciplinary Ctr Biomed Res, Lab Ophthalmol, I-00155 Rome, Italy
[2] Hosp San Raffaele, Dept Ophthalmol, I-20132 Milan, Italy
[3] GB Bietti Eye Fdn, Rome, Italy
关键词
neurotrophic keratitis; pathogenesis; medical treatment; surgical treatment; growth factors; neuropeptides;
D O I
10.1038/sj.eye.6700616
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Neurotrophic keratopathy is a degenerative corneal disease induced by an impairment of trigeminal nerve. Impairment of loss of corneal sensory innervation is responsible for corneal epithelial defects, ulcer, and perforation. In the present report, we reviewed the pathogenesis, diagnosis, and therapeutic aspects of this disease. An accurate history and clinical examination, including the function of cranial nerves, together with the clinical features of the ocular surface are essential for a prompt diagnosis. The evaluation of the corneal sensitivity and tear film function are important diagnostic steps as well. Specific medical and surgical treatments, based on the clinical staging of the disease, are often able to halt its progression. Future developments in the medical treatment including the administration of neuropeptide and growth factors are presented.
引用
收藏
页码:989 / 995
页数:7
相关论文
共 53 条
[1]   NEUROPARALYTIC KERATITIS AND THE EFFECT OF CERVICAL SYMPATHECTOMY FOLLOWING OPERATIVE PROCEDURES FOR TRIGEMINAL NEURALGIA [J].
ADAMS, GGW ;
CULLEN, JF .
SCOTTISH MEDICAL JOURNAL, 1987, 32 (03) :86-88
[2]  
Alper M G, 1975, Trans Am Ophthalmol Soc, V73, P323
[3]   Topical treatment with nerve growth factor for neurotrophic keratitis [J].
Bonini, S ;
Lambiase, A ;
Rama, P ;
Caprioglio, G ;
Aloe, L .
OPHTHALMOLOGY, 2000, 107 (07) :1347-1351
[4]   Neurotrophic and anhidrotic keratopathy treated with substance P and insulin like growth factor 1 [J].
Brown, SM ;
Lamberts, DW ;
Reid, TW ;
Nishida, T ;
Murphy, CJ .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (07) :926-927
[5]  
CAVANAGH HD, 1989, ACTA OPHTHALMOL, V67, P115
[6]  
CAVANAGH HD, 1979, OCULAR SURFACE INT O, V19, P197
[7]   Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I [J].
Chikama, T ;
Fukuda, K ;
Morishige, N ;
Nishida, T .
LANCET, 1998, 351 (9118) :1783-1784
[8]  
COBO LM, 1988, CORNEA, V7, P50
[9]   TREATMENT OF PERSISTENT EPITHELIAL DEFECTS IN NEUROTROPHIC KERATITIS WITH EPIDERMAL GROWTH-FACTOR - A PRELIMINARY OPEN STUDY [J].
DANIELE, S ;
GILBARD, JP ;
SCHEPENS, CL .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 1992, 230 (04) :314-317
[10]   Neurotrophic keratitis [J].
Davis, EA ;
Dohlman, CH .
INTERNATIONAL OPHTHALMOLOGY CLINICS, 2001, 41 (01) :1-11